Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × Gastroscopy × Clear all

Phase

Phase NA 6 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1/2 1

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1

Interventions

Cisplatin 249 Radiotherapy 206 Fluorouracil 178 Cyclophosphamide 168 Capecitabine 168 Docetaxel 147 Oxaliplatin 145 Gemcitabine 137 Carboplatin 132 Paclitaxel 131 Dexamethasone 111 Leucovorin 107 Drug Therapy 102 Doxorubicin 99 Etoposide 86 Cytarabine 77 Bevacizumab 77 Vincristine 73 Irinotecan 69 Rituximab 66 Epirubicin 64 Prednisone 58 Methotrexate 56 Radiosurgery 53 Radiation 53 Surgical Procedures, Operative 51 Radiotherapy, Intensity-Modulated 50 Lenalidomide 49 Neoadjuvant Therapy 48 Letrozole 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07016737 2025-06-12

ESO-Nanjing12

Jiangsu Cancer Institute & Hospital

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡